Formycon Future Growth
Future criteria checks 5/6
Formycon is forecast to grow earnings and revenue by 31.5% and 33.4% per annum respectively. EPS is expected to grow by 27.2% per annum. Return on equity is forecast to be 13.4% in 3 years.
Key information
31.5%
Earnings growth rate
27.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 33.4% |
| Future return on equity | 13.4% |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 179 | 93 | 65 | 104 | 7 |
| 12/31/2025 | 91 | 10 | -22 | 34 | 8 |
| 12/31/2024 | 60 | -11 | -67 | -19 | 8 |
| 6/30/2024 | 61 | 64 | -59 | -33 | N/A |
| 3/31/2024 | 69 | 70 | -45 | -21 | N/A |
| 12/31/2023 | 78 | 76 | -31 | -10 | N/A |
| 9/30/2023 | 73 | 17 | -43 | -13 | N/A |
| 6/30/2023 | 69 | -42 | -54 | -17 | N/A |
| 3/31/2023 | 56 | -3 | -50 | -18 | N/A |
| 12/31/2022 | 42 | 36 | -46 | -19 | N/A |
| 9/30/2022 | 38 | 57 | -32 | -17 | N/A |
| 6/30/2022 | 34 | 77 | -19 | -16 | N/A |
| 3/31/2022 | 35 | 32 | -17 | -15 | N/A |
| 12/31/2021 | 37 | -13 | -14 | -13 | N/A |
| 9/30/2021 | 37 | -15 | N/A | N/A | N/A |
| 6/30/2021 | 38 | -15 | -12 | -11 | N/A |
| 3/31/2021 | 36 | -11 | -9 | -8 | N/A |
| 12/31/2020 | 34 | -7 | -5 | -4 | N/A |
| 9/30/2020 | 33 | -4 | N/A | N/A | N/A |
| 6/30/2020 | 32 | -3 | 12 | 13 | N/A |
| 3/31/2020 | 33 | -3 | 5 | 6 | N/A |
| 12/31/2019 | 33 | -2 | -2 | -1 | N/A |
| 9/30/2019 | 34 | -2 | N/A | N/A | N/A |
| 6/30/2019 | 36 | -1 | -17 | -16 | N/A |
| 3/31/2019 | 39 | 3 | -2 | -1 | N/A |
| 12/31/2018 | 43 | 7 | 12 | 13 | N/A |
| 9/30/2018 | 44 | 8 | 10 | 11 | N/A |
| 6/30/2018 | 45 | 9 | 7 | 8 | N/A |
| 3/31/2018 | 37 | 4 | N/A | 2 | N/A |
| 12/31/2017 | 29 | -2 | N/A | -4 | N/A |
| 9/30/2017 | 24 | -4 | N/A | -3 | N/A |
| 6/30/2017 | 19 | -6 | N/A | -2 | N/A |
| 3/31/2017 | 19 | -5 | N/A | -4 | N/A |
| 12/31/2016 | 20 | -4 | N/A | -5 | N/A |
| 9/30/2016 | 18 | -3 | N/A | -4 | N/A |
| 6/30/2016 | 16 | -2 | N/A | -2 | N/A |
| 3/31/2016 | 16 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 17 | 1 | N/A | 1 | N/A |
| 9/30/2015 | 19 | 0 | N/A | 0 | N/A |
| 6/30/2015 | 22 | 0 | N/A | 0 | N/A |
| 3/31/2015 | 17 | 0 | N/A | 0 | N/A |
| 12/31/2014 | 13 | 1 | N/A | 0 | N/A |
| 12/31/2013 | 0 | -8 | N/A | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FYB's forecast earnings growth (31.5% per year) is above the savings rate (1%).
Earnings vs Market: FYB's earnings (31.5% per year) are forecast to grow faster than the German market (20.9% per year).
High Growth Earnings: FYB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FYB's revenue (33.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: FYB's revenue (33.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FYB's Return on Equity is forecast to be low in 3 years time (13.4%).